세계의 원료의약품(API) 시장

The global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

The chemical synthesis market for APIs is estimated to increase from $181.3 billion in 2023 to reach $246.1 billion by 2029, at a CAGR of 5.4% from 2024 through 2029.

The biotech market for APIs is estimated to increase from $66.5 billion in 2023 to reach $101.7 billion by 2029, at a CAGR of 7.4% from 2024 through 2029.

Report Scope

This goal of this report is to impart in-depth knowledge of the global market for active pharmaceutical ingredients (APIs), in terms of both qualitative and quantitative data, to help readers assess the market landscape, develop business/growth strategies, and analyze their market position. BCC Research estimates market size for 2023 (the base year) and forecasts values for 2024 by the end of 2029. It is important to note that market size reflects the demand for APIs within a region or country rather than the API industry itself.

In this report, the API market is analyzed by manufacturer type, production method, molecule type, region and country. Industry growth trends, drivers, restraints and opportunities in the API market are also discussed in detail. The scope of the study is global.

Report Includes

• 64 data tables and 38 additional tables
• An analysis of the global markets for active pharmaceutical ingredients (APIs)
• Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecast for 2025, and projected CAGRs through 2029
• Estimates of the size and revenue prospects of the global market, along with a market share analysis by origin, drug molecular entity type, manufacturer type, end use and region
• Facts and figures pertaining to the market dynamics, technical advances, API sources, production methods, route of synthesis, regulations, and the impact of macroeconomic variables
• A Porter's Five Forces model, and global supply chain and PESTLE analyses
• Patent activity featuring issues like patent expiry and its impact on the pharmaceutical market, and details of changes in pharmaceutical drug development
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Pfizer Inc., Thermo Fisher Scientific Inc., EuroAPI, Lonza, Siegfried Holding AG, and Divi's Laboratories Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• APIs Defined
• Global API Supply Chain
• API Production Methods
• API Production: Route of Synthesis
• Production Methods

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Resilient Pharmaceutical Demand
• Increase in Adoption of Generics
• Shift to More Complex Chemical Entities
• Growth in the Biologics Market
• Advances in API Manufacturing
• Government Support
• Market Restraints
• Strict Regulations and Compliance Requirements
• Pricing Pressure in the Generic API Industry
• Shortage of Skilled Professionals
• Market Trends
• Increasing Demand for Complex APIs
• Regional Diversification and Supply Chain Resilience
• Continuous Flow Manufacturing
• Expansion of Single-Use Technologies
• Growing Sustainability Practices in API Manufacturing
• Increased Outsourcing and CDMO Partnerships

Chapter 4 Emerging Technologies and Developments

• Biocatalysis for Complex Synthetic API Manufacturing
• Integration of AI and ML
• Flexible Manufacturing

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• API Market, by Manufacturer Type
• Captive and Contract Manufacturing Market
• Merchant Market
• API Market, by Production Method
• Chemical Synthesis
• Biotech
• API Market, by Molecule Type
• Small-Molecule APIs
• Large Molecule
• Geographic Breakdown
• API Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Supplier Landscape
• Captive Manufacturers
• Contract Manufacturers
• Merchant Manufacturers
• Generic API Market Landscape
• Innovative API Market Landscape
• Porter's Five Forces Analysis

Chapter 7 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AUROBINDO PHARMA
• DIVI'S LABORATORIES LTD.
• EUROAPI
• EVONIK INDUSTRIES AG
• LONZA
• PFIZER INC.
• SIEGFRIED HOLDING AG
• TEVA PHARMACEUTICAL INDUSTRIES LTD.
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC